# ASCL1

## Overview
The ASCL1 gene encodes the achaete-scute family bHLH transcription factor 1, a critical protein involved in the regulation of neurogenesis. This transcription factor is categorized as a basic helix-loop-helix (bHLH) protein, which plays a pivotal role in the differentiation of neural progenitor cells into neurons. ASCL1 is essential for the development of the nervous system, influencing the fate of various neuronal subtypes and contributing to the formation of the autonomic nervous system (Castro2011A; Chouchane2019Instructing). The protein's activity is modulated through interactions with other proteins and post-translational modifications, such as phosphorylation, which affect its stability and function (Baronti2017FragmentBased; Ali2014The). ASCL1's dysregulation is implicated in several cancers and neurodevelopmental disorders, highlighting its significance in both normal development and disease states (Vue2020ASCL1; Borromeo2016ASCL1).

## Structure
The ASCL1 protein, encoded by the ASCL1 gene, is a transcription factor involved in neuronal differentiation. It consists of 236 amino acids and is divided into three main domains: an N-terminal region, a basic helix-loop-helix (bHLH) domain, and a C-terminal region. The N-terminal region (residues 1-121) contains polyA and polyQ stretches, with the polyA segment showing a high propensity to adopt an alpha-helical conformation (Baronti2017FragmentBased). The central bHLH domain (residues 122-179) is responsible for dimerization and DNA binding, with its basic region crucial for these functions. This domain is more structured compared to the rest of the protein, although it does not fully form a stable HLH motif (Baronti2017FragmentBased). The C-terminal region (residues 180-236) is rich in Ser-Pro pairs and is involved in intermolecular interactions, being subject to phosphorylation by proline-directed kinases, which regulates ASCL1 activity (Baronti2017FragmentBased).

ASCL1 is characterized by structural heterogeneity, with three helical segments and a highly disordered polypeptide chain that facilitates transient interactions with kinases and regulatory proteins (Baronti2017FragmentBased). The protein's quaternary structure involves dimerization, particularly in the bHLH domain, which is influenced by its environment and interactions with DNA (Baronti2017FragmentBased). Post-translational modifications, such as phosphorylation on serine-proline sites, play a significant role in regulating ASCL1's activity and stability (Ali2014The).

## Function
The ASCL1 gene, also known as achaete-scute family bHLH transcription factor 1, is a crucial regulator in neurogenesis, particularly in the embryonic brain. It functions as a proneural transcription factor that promotes the transition of neural progenitor cells from proliferation to differentiation into neurons (Castro2011A). ASCL1 is involved in the regulation of the cell cycle in neural progenitors by activating genes that promote cell cycle progression, such as E2f1, Cdk1, and Cdk2, which are essential for the G1/S transition and entry into mitosis (Castro2011A). It also targets genes involved in cell proliferation and angiogenesis, like FoxM1 and Cyr61/Ccn1 (Castro2011A).

ASCL1 plays a dual role by also regulating genes that induce cell cycle arrest, facilitating the switch from a proliferating progenitor state to a post-mitotic neuronal state (Castro2011A). It is active in the nucleus, where it binds to E-box sequences in DNA to activate the transcription of genes essential for neuronal development (Castro2011A). ASCL1's role extends to the development of the autonomic nervous system and influences the fate of neural crest cells, contributing to the generation of various neuronal subtypes, including GABAergic, glutamatergic, noradrenergic, and cholinergic neurons (Chouchane2019Instructing).

## Clinical Significance
ASCL1 is implicated in various cancers and neurodevelopmental disorders due to its role as a transcription factor. In lung adenocarcinoma, ASCL1 expression is associated with neuroendocrine differentiation and is more prevalent in smokers. This subtype often lacks EGFR mutations and shows poor immune cell infiltration, which may affect treatment responses, particularly to PD-1 and PD-L1 checkpoint inhibitors (Miyashita2018An). ASCL1 is also highly expressed in small cell lung cancer (SCLC), where it regulates oncogenic and neural-associated genes crucial for tumor survival and proliferation (Borromeo2016ASCL1).

In gliomas, ASCL1 regulates neurodevelopmental transcription factors and cell cycle genes, contributing to tumor proliferation. Its expression is notably high in glioblastoma multiforme (GBM), particularly in the proneural and classical subtypes (Vue2020ASCL1). In prostate cancer, ASCL1 is involved in the transition to neuroendocrine prostate cancer (NEPC), promoting a neuronal stem cell-like lineage, which is associated with treatment resistance (Nouruzi2022ASCL1).

ASCL1 overexpression in chronic lymphocytic leukemia (CLL) is linked to a chromosomal translocation, leading to the upregulation of genes involved in neuroendocrine differentiation (Malli2018Overexpression). In neuropsychiatric disorders, variations in ASCL1 are associated with Parkinson's disease, potentially influencing predispositions through interactions with PHOX2B (Ide2005Genetic).

## Interactions
ASCL1, a basic helix-loop-helix (bHLH) transcription factor, is known for its role in neurogenesis and interacts with various proteins and nucleic acids. ASCL1 directly binds to the promoter regions of genes such as NDRG1 and EGFR, indicating that these are direct transcriptional targets. This binding was confirmed through chromatin immunoprecipitation (ChIP) analyses, suggesting ASCL1's role in transcriptional regulation by physically interacting with DNA (Narayanan2018The).

ASCL1 also interacts with the transcription factor FOXO3, sharing common genomic targets. Although there is no evidence of a direct physical interaction between ASCL1 and FOXO3, they both bind to genes involved in the Notch signaling pathway, such as Dll1 and Hes6. FOXO3 inhibits ASCL1-dependent transcription, potentially through a displacement model where both factors cannot bind simultaneously to certain loci (Webb2013FOXO3).

In the developing nervous system, ASCL1 interacts with MTGR1, a member of the MTG family of proteins. MTGR1 binds to ASCL1 using multiple interaction surfaces, forming a repressor complex that modulates ASCL1's transcriptional activity (Aaker2010Interaction). These interactions highlight ASCL1's complex role in regulating gene expression and neurogenesis.


## References


[1. (Castro2011A) Diogo S. Castro, Ben Martynoga, Carlos Parras, Vidya Ramesh, Emilie Pacary, Caroline Johnston, Daniela Drechsel, Mélanie Lebel-Potter, Laura Galinanes Garcia, Charles Hunt, Dirk Dolle, Angela Bithell, Laurence Ettwiller, Noel Buckley, and François Guillemot. A novel function of the proneural factor ascl1 in progenitor proliferation identified by genome-wide characterization of its targets. Genes &amp; Development, 25(9):930–945, May 2011. URL: http://dx.doi.org/10.1101/gad.627811, doi:10.1101/gad.627811. This article has 355 citations.](https://doi.org/10.1101/gad.627811)

[2. (Nouruzi2022ASCL1) Shaghayegh Nouruzi, Dwaipayan Ganguli, Nakisa Tabrizian, Maxim Kobelev, Olena Sivak, Takeshi Namekawa, Daksh Thaper, Sylvan C. Baca, Matthew L. Freedman, Adeleke Aguda, Alastair Davies, and Amina Zoubeidi. Ascl1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer. Nature Communications, April 2022. URL: http://dx.doi.org/10.1038/s41467-022-29963-5, doi:10.1038/s41467-022-29963-5. This article has 54 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-022-29963-5)

[3. (Narayanan2018The) Ashwin Narayanan, Filippo Gagliardi, Alberto L. Gallotti, Stefania Mazzoleni, Manuela Cominelli, Luca Fagnocchi, Mauro Pala, Ignazio S. Piras, Paola Zordan, Nicole Moretta, Elisa Tratta, Gianluca Brugnara, Luisa Altabella, Giuseppina Bozzuto, Petra Gorombei, Agnese Molinari, Rose-Ann Padua, Alessandro Bulfone, Letterio S. Politi, Andrea Falini, Antonella Castellano, Pietro Mortini, Alessio Zippo, Pietro L. Poliani, and Rossella Galli. The proneural gene ascl1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene ndrg1. Cell Death &amp; Differentiation, 26(9):1813–1831, December 2018. URL: http://dx.doi.org/10.1038/s41418-018-0248-7, doi:10.1038/s41418-018-0248-7. This article has 42 citations.](https://doi.org/10.1038/s41418-018-0248-7)

[4. (Webb2013FOXO3) Ashley E. Webb, Elizabeth A. Pollina, Thomas Vierbuchen, Noelia Urbán, Duygu Ucar, Dena S. Leeman, Ben Martynoga, Madhavi Sewak, Thomas A. Rando, François Guillemot, Marius Wernig, and Anne Brunet. Foxo3 shares common targets with ascl1 genome-wide and inhibits ascl1-dependent neurogenesis. Cell Reports, 4(3):477–491, August 2013. URL: http://dx.doi.org/10.1016/j.celrep.2013.06.035, doi:10.1016/j.celrep.2013.06.035. This article has 130 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.celrep.2013.06.035)

[5. (Chouchane2019Instructing) Malek Chouchane and Marcos R. Costa. Instructing neuronal identity during cns development and astroglial-lineage reprogramming: roles of neurog2 and ascl1. Brain Research, 1705:66–74, February 2019. URL: http://dx.doi.org/10.1016/j.brainres.2018.02.045, doi:10.1016/j.brainres.2018.02.045. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.brainres.2018.02.045)

[6. (Baronti2017FragmentBased) Lorenzo Baronti, Tomáš Hošek, Sergio Gil-Caballero, Hadas Raveh-Amit, Eduardo O. Calçada, Isabel Ayala, András Dinnyés, Isabella C. Felli, Roberta Pierattelli, and Bernhard Brutscher. Fragment-based nmr study of the conformational dynamics in the bhlh transcription factor ascl1. Biophysical Journal, 112(7):1366–1373, April 2017. URL: http://dx.doi.org/10.1016/j.bpj.2017.02.025, doi:10.1016/j.bpj.2017.02.025. This article has 8 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.bpj.2017.02.025)

[7. (Malli2018Overexpression) Theodora Malli, Melanie Rammer, Sabrina Haslinger, Jonathan Burghofer, Sonja Burgstaller, Hans-Christian Boesmueller, Renate Marschon, Wolfgang Kranewitter, Martin Erdel, Sabine Deutschbauer, and Gerald Webersinke. Overexpression of the proneural transcription factor ascl1 in chronic lymphocytic leukemia with a t(12;14)(q23.2;q32.3). Molecular Cytogenetics, January 2018. URL: http://dx.doi.org/10.1186/s13039-018-0355-7, doi:10.1186/s13039-018-0355-7. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13039-018-0355-7)

[8. (Aaker2010Interaction) Joshua D. Aaker, Andrea L. Patineau, Hyun-jin Yang, David T. Ewart, Yasushi Nakagawa, Steven C. McLoon, and Naoko Koyano-Nakagawa. Interaction of mtg family proteins with neurog2 and ascl1 in the developing nervous system. Neuroscience Letters, 474(1):46–51, April 2010. URL: http://dx.doi.org/10.1016/j.neulet.2010.03.004, doi:10.1016/j.neulet.2010.03.004. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.neulet.2010.03.004)

[9. (Ali2014The) Fahad R. Ali, Kevin Cheng, Peter Kirwan, Su Metcalfe, Frederick J. Livesey, Roger A. Barker, and Anna Philpott. The phosphorylation status of ascl1 is a key determinant of neuronal differentiation and maturation in vivo and in vitro. Development, 141(11):2216–2224, June 2014. URL: http://dx.doi.org/10.1242/dev.106377, doi:10.1242/dev.106377. This article has 77 citations and is from a peer-reviewed journal.](https://doi.org/10.1242/dev.106377)

[10. (Vue2020ASCL1) Tou Yia Vue, Rahul K. Kollipara, Mark D. Borromeo, Tyler Smith, Tomoyuki Mashimo, Dennis K. Burns, Robert M. Bachoo, and Jane E. Johnson. <scp>ascl1</scp> regulates neurodevelopmental transcription factors and cell cycle genes in brain tumors of glioma mouse models. Glia, 68(12):2613–2630, June 2020. URL: http://dx.doi.org/10.1002/glia.23873, doi:10.1002/glia.23873. This article has 28 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/glia.23873)

[11. (Miyashita2018An) Naoya Miyashita, Masafumi Horie, Hiroshi I. Suzuki, Masahito Yoshihara, Dijana Djureinovic, Johan Persson, Hans Brunnström, Cecilia Lindskog, Hedvig Elfving, Patrick Micke, Akira Saito, and Takahide Nagase. An integrative analysis of transcriptome and epigenome features of ascl1–positive lung adenocarcinomas. Journal of Thoracic Oncology, 13(11):1676–1691, November 2018. URL: http://dx.doi.org/10.1016/j.jtho.2018.07.096, doi:10.1016/j.jtho.2018.07.096. This article has 21 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jtho.2018.07.096)

[12. (Ide2005Genetic) Masayuki Ide, Kazuo Yamada, Tomoko Toyota, Yoshimi Iwayama, Yuichi Ishitsuka, Yoshio Minabe, Kazuhiko Nakamura, Nobutaka Hattori, Takashi Asada, Yoshikuni Mizuno, Norio Mori, and Takeo Yoshikawa. Genetic association analyses of phox2b and ascl1 in neuropsychiatric disorders: evidence for association of ascl1 with parkinson’s disease. Human Genetics, 117(6):520–527, July 2005. URL: http://dx.doi.org/10.1007/s00439-005-1342-8, doi:10.1007/s00439-005-1342-8. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00439-005-1342-8)

[13. (Borromeo2016ASCL1) Mark D. Borromeo, Trisha K. Savage, Rahul K. Kollipara, Min He, Alexander Augustyn, Jihan K. Osborne, Luc Girard, John D. Minna, Adi F. Gazdar, Melanie H. Cobb, and Jane E. Johnson. Ascl1 and neurod1 reveal heterogeneity in pulmonary neuroendocrine tumors and regulate distinct genetic programs. Cell Reports, 16(5):1259–1272, August 2016. URL: http://dx.doi.org/10.1016/j.celrep.2016.06.081, doi:10.1016/j.celrep.2016.06.081. This article has 364 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.celrep.2016.06.081)